Who we are

PharmaLex China is the Chinese office of the PharmaLex Group. PharmaLex China acts as a liaison office to set up cooperations and extend exchange with the PharmaLex Group and our local Chinese partner company.

  • Through the liaison office PharmaLex China covers all services required by health agencies worldwide and partners with customers from China to provide solutions for their international needs.
  • We help customers in China to access mature markets like the US and Europe.
  • Our Chinese partner is able to understand local nuances of the regulatory framework for international clients interested in the Chinese market.
  • Our goal is to offer enhanced regulatory support to customers throughout China’s pharma market.

Local Contact

  • China

What our clients say about us

We are working with a number of large pharma companies and are looking to create a consortium of partners to collect feedback on expertise, availability and outcomes. If you would be interested in joining our consortium, please contact us on contact@pharmalex.com.

  • I just wanted to relay our sincere thanks to you and the team for two really excellent days training. It was well organized and structured to cover regulatory expectations, GMP principle and routine work challenges of industry. The presenters and moderator were highly skilled in this area to accommodate any queries raised during the training session and were well able to keep the team engaged even in remote/virtual training session. The design of training slides was impressive and the use of technology to make virtual training was remarkable.

    Lorraine Henry
    Compliance Lead, Qualified Person, Amneal Ireland Limited
  • There was a close relationship between the regulatory strategy and the writing activities. You developed a fine-tuned regulatory strategy which will be a key factor to smooth the approval of our dossier.

    Large Pharma, Global
    VP Regulatory Strategy
  • We really appreciate your responsiveness and availability during our previous exchanges and it is what we are waiting for from our partner.

    Small Medium Sized Company, UK
    Head of Regulatory Affairs
  • In these unprecedented times, PharmaLex continues to support all clients by meeting virtually and providing experienced, remote-based consultants.

    Thomas Dobmeyer, CEO PharmaLex
    CEO PharmaLex